A randomised control trial to assess efficacy of platelet rich fibrin in tympanoplasty.
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Dr Nikhil Vallathukaran Mathew
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- To assess to graft uptake following application of platelet rich fibrin.
Overview
Brief Summary
This study is a randomised, single blinded, parallel group, single centre trial comparing the improved outcome with the use of platelet rich fibrin in Tympanoplasty ear surgery as compared with conventional technique without using the platelet rich fibrin.This study will be done for 15 month over 60 patients with chronic suppurative otitis media(Inactive) with no comorbidities. The primary outcome will measure the graft take up at 1st week, 1st month and 3rd month. The healing rate of of perforation and hearing improvement post tympanoplasty is also assessed at 3rd months.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 20.00 Year(s) to 40.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Chronic Suppurative Otiti Media- Tubotympanic Disease(Inactive).
Exclusion Criteria
- •Comorbities like Diabetes Mellitus, Hypertension, Bronchial Asthma, Tuberculosis.
Outcomes
Primary Outcomes
To assess to graft uptake following application of platelet rich fibrin.
Time Frame: At end of 1 week, 1 month and 3rd month
Secondary Outcomes
- To assess the rate of healing.(At end of 1 week,1 month and 3 month)
- To assess the hearing improvement post tympanoplasty(At end of 3 months)